These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34772407)

  • 1. Dexmedetomidine inhibits mitochondria damage and apoptosis of enteric glial cells in experimental intestinal ischemia/reperfusion injury via SIRT3-dependent PINK1/HDAC3/p53 pathway.
    Zhang Q; Liu XM; Hu Q; Liu ZR; Liu ZY; Zhang HG; Huang YL; Chen QH; Wang WX; Zhang XK
    J Transl Med; 2021 Nov; 19(1):463. PubMed ID: 34772407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine Ameliorates Cardiac Ischemia/Reperfusion Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT3 Pathway.
    He H; Liu P; Li P
    Drug Des Devel Ther; 2023; 17():3205-3218. PubMed ID: 37908314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine protects intestinal ischemia-reperfusion injury via inhibiting p38 MAPK cascades.
    Liu XM; Chen QH; Hu Q; Liu Z; Wu Q; Liang SS; Zhang HG; Zhang Q; Zhang XK
    Exp Mol Pathol; 2020 Aug; 115():104444. PubMed ID: 32335082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine Confers Protection Against Neuronal Oxygen Glucose Deprivation-Reperfusion by Regulating SIRT3 Mediated Autophagy.
    Fu Z; Pang Z; He L; Zhang L; Fan Y; Zhao C; Yang J
    Neurochem Res; 2022 Nov; 47(11):3490-3505. PubMed ID: 36042140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats.
    Yu W; Lyu J; Jia L; Sheng M; Yu H; Du H
    Oxid Med Cell Longev; 2020; 2020():7385458. PubMed ID: 34493950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats.
    Hu B; Tian T; Li XT; Hao PP; Liu WC; Chen YG; Jiang TY; Chen PS; Cheng Y; Xue FS
    Redox Rep; 2023 Dec; 28(1):2158526. PubMed ID: 36738240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine Preconditioning Attenuates Myocardial Ischemia/Reperfusion Injury in Rats by Suppressing Mitophagy Via Activating Α2-Adrenergic Receptor.
    Chen Y; Chen H; Chen Y; Yang Z; Zhou T; Xu W
    Arq Bras Cardiol; 2023 Oct; 120(10):e20220750. PubMed ID: 37909577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
    Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W
    J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine protects hippocampal neurons against hypoxia/reoxygenation-induced apoptosis through activation HIF-1α/p53 signaling.
    Gao Y; Yin H; Zhang Y; Dong Y; Yang F; Wu X; Liu H
    Life Sci; 2019 Sep; 232():116611. PubMed ID: 31260683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats.
    Zhang XY; Liu ZM; Wen SH; Li YS; Li Y; Yao X; Huang WQ; Liu KX
    Anesthesiology; 2012 May; 116(5):1035-46. PubMed ID: 22417965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine against intestinal ischemia/reperfusion injury: A systematic review and meta-analysis of preclinical studies.
    Hou M; Chen F; He Y; Tan Z; Han X; Shi Y; Xu Y; Leng Y
    Eur J Pharmacol; 2023 Nov; 959():176090. PubMed ID: 37778612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine (DEX) protects against hepatic ischemia/reperfusion (I/R) injury by suppressing inflammation and oxidative stress in NLRC5 deficient mice.
    Chen Z; Ding T; Ma CG
    Biochem Biophys Res Commun; 2017 Nov; 493(2):1143-1150. PubMed ID: 28784305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of dexmedetomidine against diabetic hyperglycemia-exacerbated cerebral ischemia/reperfusion injury: An in vivo and in vitro study.
    Chen L; Cao J; Cao D; Wang M; Xiang H; Yang Y; Ying T; Cong H
    Life Sci; 2019 Oct; 235():116553. PubMed ID: 31185237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine Alleviates Ischemia/Reperfusion-Associated Acute Kidney Injury by Enhancing Autophagic Activity
    Zhou BY; Yang J; Luo RR; Sun YL; Zhang HT; Yang AX; Zhang GX
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):323. PubMed ID: 38179733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine attenuates spinal cord ischemia-reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits.
    Sun Z; Zhao T; Lv S; Gao Y; Masters J; Weng H
    J Transl Med; 2018 Jul; 16(1):209. PubMed ID: 30031397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
    Chang JH; Jin MM; Liu JT
    Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine reduces enteric glial cell injury induced by intestinal ischaemia-reperfusion injury through mitochondrial localization of TERT.
    Hu Q; Liu XM; Liu ZR; Liu ZY; Zhang HG; Zhang Q; Huang YL; Chen QH; Wang WX; Zhang X
    J Cell Mol Med; 2022 May; 26(9):2594-2606. PubMed ID: 35366055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway.
    Xue BB; Chen BH; Tang YN; Weng CW; Lin LN
    Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats.
    Bao N; Dai D
    Mediators Inflamm; 2020; 2020():2120971. PubMed ID: 32317860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
    Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H
    Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.